SCHEMBL3595682

SCHEMBL3595682

C=CCOCC(C)Oc1cc(Br)cc(C(=O)O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 13/20 0.35
PLA2G2A P14555 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
THRA P10827 1/20 0.32
THRB P10828 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605804 0.86 PLA2G2A (0.35) PLA2G2AALDH1A1KDM4EMEN1NPC1
SCHEMBL3605375 0.81 GCK (0.49) GCKPLA2G2ARARARARBRARG
SCHEMBL3588948 0.79 MEN1 (0.48) GCKRARARARBMEN1LMNA
SCHEMBL3592345 0.79 ICMT (0.30)
SCHEMBL3595570 0.78 GCK (0.37) GCKPLA2G2ARARARARBRARG
SCHEMBL2172360 0.78 GCK (0.37) GCKPLA2G2ARARARARBRARG
SCHEMBL3599402 0.77 GCK (0.55) GCK
SCHEMBL5186590 0.75 PLA2G2A (0.51) PLA2G2AALDH1A1RARBKDM4EMEN1
SCHEMBL29784105 0.75 KMT2A (0.55) GCKPLA2G2AALDH1A1RARARARB
SCHEMBL2657385 0.75 KMT2A (0.55) GCKPLA2G2AALDH1A1RARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101039901-B Process for making phenoxy benzamide compounds ASTRAZENECA AB 2011-03-09 CN disclosed
US-7700640-B2 Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2010-04-20 US disclosed
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds ASTRAZENECA AB (SE) 2008-08-21 US disclosed
CN-101039901-A Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2007-09-19 CN disclosed
EP-1802570-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS AstraZeneca AB (SE) 2007-07-04 EP disclosed
WO-2006040527-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds PAH, MAOB, TYR GCK 1415/4885PLA2G2A 3616/4885ALDH1A1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.